The Clinical Trials Network executive welcomes four new members

30 March 2022

Associate Professor Lis Evered, Dr Doug Campbell, Dr Jennifer Reilly and Associate Professor Stefan Dieleman have been appointed as members of the CTN Executive.

After a thorough and competitive recruitment process, the CTN executive is excited to welcome some of the next generation of research leaders to meet the changing needs of the CTN executive in terms of sustainability, diversity, future proofing and growth. Associate Professor Lis Evered, Dr Doug Campbell, Dr Jennifer Reilly and Associate Professor Stefan Dieleman have been appointed as members of the CTN executive. Each of these research leaders are experts in their own fields and will bring new ideas, talent, diversity and vibrancy to the executive.

The change to the CTN Executive membership and the revised terms of reference is part of the CTN’s strategic plan for long standing executive members or ‘pioneers’ to step down to allow for a dynamic representative executive to serve the wider CTN.

Congratulations to our new members on being appointed to the CTN executive. We thank all applicants for their interest and ongoing engagement with the Clinical Trials Network. Further vacancies will be advertised in 2023.